Stressors activate the hypothalamic-pituitary-adrenal (HPA) axis and immune system eliciting changes 30 in cognitive function, mood and anxiety. An important link between stress and altered behavior is stimulation of 31 the Kynurenine Pathway which generates neuroactive and immunomodulatory kynurenines. Tryptophan entry 32 into this pathway is controlled by rate-limiting indoleamine/tryptophan 2,3-dioxygenases (DOs: Ido1, Ido2, 33 Tdo2). Although implicated as mediating changes in behavior, detecting stress-induced DO expression has 34 proven inconsistent. Thus, C57BL/6J mice were used to characterize DO expression in brain-regions, astrocytes 35 and microglia to characterize restraint-stress-induced DO expression. Stress increased kynurenine in brain and 36 plasma, demonstrating increased DO activity. Of three Ido1 transcripts, only Ido1-v1 expression was increased 37 by stress and within astrocytes, not microglia, indicating transcript-and glial-specificity. Stress increased Ido1-38 v1 only in frontal cortex and hypothalamus, indicating brain-region specificity. Of eight Ido2 transcripts, Ido2-39 v3 expression was increased by stress, again only within astrocytes. Likewise, stress increased Tdo2-FL 40 expression in astrocytes, not microglia. Interestingly, Ido2 and Tdo2 transcripts were not correspondingly 41 induced in Ido1-knockout (Ido1 KO ) mice, suggesting that Ido1 is necessary for the central DO response to acute 42 stress. Unlike acute inflammatory models resulting in DO induction within microglia, only astrocyte DO 43 expression was increased by acute restraint-stress, defining their unique role during stress-dependent activation 44 of the Kynurenine Pathway. 45 46
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has investigated the regulation of DOs by stress within the CNS and periphery, the cellular origins responsible 84 for DO induction remain undefined. 85 Kynurenine itself is not considered a neuroactive metabolite (McCusker et al., 2014) , albeit increased 86 DO activity is required for depression-like behaviors following stress (Gibney et al., 2014; Liu et al., 2015) . 87
Instead, Kyn is further metabolized down the Kynurenine Pathway into other neuroactive metabolites, i.e. 88 kynurenines. This is especially relevant to the CNS, owing to the remarkable cellular specificity in the 89 production of kynurenines (McCusker et al., 2014) . Most notably, astrocytes are enzymatically equipped to 90 produce kynurenic acid (KynA) a glutamate (NMDA) and acetylcholine (α 7 nACh) receptor antagonist 91 (Guillemin et al., 2001; Wu et al., 2010) , while microglia produce quinolinic acid (QuinA) and 3-92 hydroxykynurenine (3-HK) which are NMDA receptor agonists (Guillemin et al., 2004; Heyes et al., 1996) . A 93 recent study found that chronic unpredictable stress increased central Ido1 and Tdo2 mRNA coincident with 94 increased KynA concentrations, but unchanged 3-HK (Dugan et al., 2016). This would suggest a specific role 95 for astrocytes in stress-induced DO induction. 96
Herein we report induction of all three DOs by acute restraint-stress specifically within astrocytes. We 97 have expanded on recent work investigating DO-regulation by stress (Vecchiarelli et al., 2015) to include the 98 regulation of recently described alternatively-spliced DO mRNA transcripts (Brooks et al., 2016a (Brooks et al., , 2016b . 99
Moreover, since acute stress increases Kyn levels in both plasma and brain (Kennett and Joseph, 1981 ; Pawlak 00 et al., 2000) , we include DO-regulation by stress in liver, the major tryptophan metabolizing organ primarily via 01
Tdo2. Finally, since there is evidence of changes in Ido2 expression within Ido1-knockout (Ido1 KO 
Materials and Methods
105 2.1. Animals 106 C57BL/6J (wild-type) or Ido1 KO mice (The Jackson Laboratory, Bar Harbor, ME, USA) were used to 107 establish breeding colonies to supply male mice for experiments. Mice were housed on a reversed 12 h light-108 dark cycle with ab lib access to food and water. Mice were individually housed at least 1 week prior to 109 experiments. Mice were 14-15 weeks of age at the time of treatment. All animal procedures were approved by 110 the Institutional Animal Care and Use Committee and performed in accordance with the Guide for the Care and 111
Use of Laboratory Animals (National Research Council). 112
Study design 113

Restraint-stress 114
Restraint-stress was initiated at the onset of the dark cycle (10 am) and maintained for 3 h using 115 ventilated syringes (Steelman et al., 2010) . Mice were euthanized 2 h after the cessation of restraint, at which 116 time wild-type mice had a significant reduction in body weight associated with restraint-stress (control change 117 in body weight 0.1 ± 0.1 g vs. restrained -0.9 ± 0.1 g, p<0.001). A similar response was seen with Ido1 KO mice 118 (control 0.4 ± 0.1 g vs. restrained -0.7 ± 0.2 g, p<0.001). 119
Following euthanasia, caval blood was collected into heparinized syringes. Samples were centrifuged 120 and plasma collected. Mice were intracardially perfused using cold PBS plus 2 mM EDTA. After perfusion, 121 samples were collected from separate cohorts of mice for either 1) whole brain sampling followed by glia 122 enrichment or 2) brain region and liver collection as described in sections 2.2.2 and 2.2.3, respectively. 123
Brain sampling and Glia enrichment: mouse cohort 1 124
Brains were removed and placed in ice-cold Hank's balanced salt solution then homogenized with a 125 M A N U S C R I P T A C C E P T E D ACCEPTED MANUSCRIPT (12. 0 ± 1.0-fold, p<0.001). Cd11b expression was greater in microglia preparations compared to brain from 138 wild-type mice (265.6 ± 10.8-fold, p<0.001). 139
Brain region and liver collection: mouse cohort 2 140
Brain-regions (prefrontal cortex (PFC), striatum (Stri), hippocampus (Hippo), hypothalamus (Hypo)) 141 and livers were collected and frozen for later RNA extraction. The remaining brain (sans PFC, Stri, Hippo and 42
Hypo) was frozen for analysis of Kyn. 43
Gene Expression by qPCR 44
RNA was extracted from brain, astrocytes, microglia, PFC, Stri, Hippo, Hypo and liver, then reverse-145 transcribed (4368813, Applied Biosystems). Resulting cDNA was used for quantitative polymerase chain 146 reaction (qPCR) using TaqMan Universal PCR Master Mix (4324020, Applied Biosystems). Expression of each 147 test gene were normalized to the reference gene (Gapdh) using the 2 -∆∆Ct method (Livak and Schmittgen, 2001). 148
Gene expression in naïve control (Ctrl) brain or Ctrl PFC is set to 1.0, with samples from the same experiments 149 expressed relative to appropriate controls. Gene structure and mRNA transcripts for the DOs are shown in Fig.  150 1. Assays designed to quantify the various DO transcripts are described in Table 1 M A N U S C R I P T
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Two-way ANOVA was used to compare the relative expression of genes between astrocytes, microglia 68 and brain, and to compare brain-regions and liver, while T-tests were used to determine the effects of stress. 69
Analysis was performed using SigmaPlot 14.0 software. Significance was set at p≤0.05. 70
Results
171
Acute stress increases gene expression of markers for HPA axis activation and inflammation 72
FK506-binding protein 51 (Fkbp51) expression was increased by restraint-stress in both brain and liver 73 ( Fig. 2A) . These data confirm a HPA axis response (Stechschulte and Sanchez, 2011; Zannas et al., 2016) . 74 Some effects of restraint-stress are mediated by increases in pro-inflammatory cytokines. Restraint-stress 75 increased IL-1β ( Fig. 2B ) and TNFα (Fig. 2C ) expression within brain, confirming an inflammatory response. 76
Although relative expression of IL-1β and TNFα was higher in liver vs. brain, a stress-induced inflammatory 77 response was not observed in liver. Also, IFNγ gene expression was unaffected by restraint-stress in brain and 78 liver. IFNγ protein concentrations in plasma from naïve and restrained mice were below detection-limits (data 79 not shown). 80
Acute stress increases plasma and brain kynurenine in wild-type, but not Ido1 KO mice 181
Plasma concentrations of Kyn were increased by restraint-stress in wild-type, but not Ido1 KO mice (Fig.  182  3A) . Brain concentrations of Kyn were also increased by stress in wild-type, but not Ido1 KO mice (Fig. 3B) .
183 Since the DOs are rate-limiting enzymes in the metabolism of Trp to Kyn (McCusker et al., 2014) , these data 84 verify restraint-stress activation of the Kynurenine Pathway and the necessity of Ido1 for increased Kyn. 85
Acute stress increases Ido1-v1 expression in astrocytes and select brain-regions 86
Ido1 expression in the mouse brain is reported to both increase and remain unchanged following acute 87 stress. Based on our nomenclature ( Fig. 1) , these studies used PCR assays amplifying either Ido1-FL (Browne et 88 al., 2012; Kiank et al., 2010) or all Ido1 transcripts simultaneously, Ido1-Tot (Gibney et al., 2014) . We 89 independently quantified expression three Ido1 transcripts to refine this issue. In agreement with our previous 90 work (Brooks et al., 2016b) , Ido1-FL and Ido1-v2 transcripts were poorly expressed in brains and livers of 191 naïve mice. Their expression was not induced by restraint-stress (data not shown). 192 Ido1-v1 is well expressed in the mouse brain and numerically, but non-significantly, elevated by 193 restraint-stress ( Fig. 4) . Initially, this suggests that Ido1-v1 expression is not altered by restraint-stress; however, 194 a more in-depth investigation reveals the nature of Ido1-v1 expression. Ido1-v1 expression is induced 4.8-fold 195 in astrocytes, but not in microglia, isolated from stressed mice. The stress effect is not only cell-type specific 96 but brain-region specific, disguising significant effects when whole-brain is assessed. Ido1-v1 expression was 197 highest in striatum followed by hypothalamus relative to other brain-regions. Restraint-stress increased Ido1-v1 M A N U S C R I P T
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in prefrontal cortex and hypothalamus. As expected, Ido1 KO mice did not express Ido1-v1 ( Fig. 4 ), Ido1-FL or 99 Ido1-v2 (not shown). Hepatic expression of Ido1-FL, Ido1-v1 and Ido1-v2 was low and not altered by stress. 00
Thus, Ido1 expression exhibits brain-region, glial and transcript-specificity within naïve and restrained wild-01 type mice. 02
Acute stress increases Ido2-v3 expression in astrocytes 03
To our knowledge, there is only one report examining the effect of stress on Ido2 expression. Using an 04 assay that detects all transcripts (Ido2-Tot), forced-swimming-associated stress increased hippocampal Ido2 05 expression in BALB/c, but not C57BL/6J, mice (Browne et al., 2012) . We quantified expression of Ido2 (Fig. 1 ) 06 for transcript-, tissue-and glial-specific responses between naïve and restrained mice. Of eight Ido2 mRNA 207 variants, restraint-stress remarkably increased the expression of only one Ido2 transcript; this transcript-208 specificity would make it difficult to detect changes when simultaneously quantifying all transcripts, i.e. Ido2-09
Tot. 10
Ido2-FL is poorly expressed in the naïve mouse brain except within the striatum where Ido2-FL 211 expression is 10-fold higher ( Fig. 5A ) than other brain-regions. In striking contrast, hepatic Ido2-FL is markedly 12 higher in relation to brain-regions. While restraint-stress had no effect on central Ido2-FL, hepatic Ido2-FL 13 expression in wild-type and Ido1 KO mice was decreased following restraint. 214
Ido2-v3 is well expressed in the mouse brain, but stress-induced changes are not realized when 215 analyzing whole-brain or brain-regions ( Fig. 5B) . The low basal expression in astrocytes and microglia relative 216 to brain indicates that most of the Ido2-v3 in naïve brain is expressed by stress-insensitive cells. Nonetheless, 217
Ido2-v3 expression is increased by stress 13-fold in astrocytes. In Ido1 KO mice, Ido2-v3 expression by 218 astrocytes is not increased by stress. In wild-type mice, hepatic expression of Ido2-v3 is greater relative to 219 brain-regions; and hepatic Ido2-v3 is decreased by stress, albeit significant only for Ido1 KO mice. 20
Ido2-v4 is also poorly expressed in the naïve mouse brain except within the striatum (Fig. 5C ) where 221 Ido2-v4 expression is highest (Brooks et al., 2016b) . Again, hepatic expression of Ido2-v4 is markedly higher in 22 relation to brain-regions. While not regulated by stress within the brain, stress decreased hepatic Ido2-v4 23 expression in wild-type and Ido1 KO mice. 224
Thus, expression of Ido2-FL, Ido2-v3 and Ido2-v4 are stress sensitive, lowered in liver and Ido2-v3 is 25 elevated in astrocytes. Other Ido2 transcripts exhibit unique patterns of expression across tissues and brain-26 regions, but their expression is relatively independent of stress (supplementary Fig. S1 ). 27
Compared to wild-type mice, the brains of Ido1 KO mice are strikingly deficient in several Ido2 28 transcripts, including 78% reduction in Ido2-v3 ( Fig. 5B ), 84% reduction in Ido2-v1, 92% reduction in Ido2-v2, 29 22% reduction in Ido2-v5, 57% reduction in Ido2-v6 and loss of detectable Ido2-v7 ( Fig. S1 ). This loss of Ido2 30 in Ido1 KO is cell-and tissue-specific, and was previously reported to occur in B-lymphocytes, but not liver 231 of Ido1 KO mice is not mediated astrocytes, as Ido2-v3 in astrocytes from Ido1 KO mice is numerically greater 234 than astrocytes from wild-type mice. Thus, loss of Ido2-v3 occurs in another cell-type within the brain. 235
Additionally, although Ido2-v3 is induced by stress in astrocytes from wild-type mice, it was not increased in 236 Ido1 KO mice. Thus, the regulation of Ido2 is transcript-, tissue-and cell-type-specific in wild-type mice, and 237 genetic deletion of Ido1 perturbs central Ido2 expression. Importantly, when interpreting physiologic 238 differences between wild-type and Ido1 KO mice, diminished Ido2 expression in the brain should be considered. 239
Acute stress increases Tdo2-FL expression in brain, astrocytes and liver 240
Tdo2 was the first DO investigated within the context of acute stress with early reports describing 241 increases in hepatic Tdo2 activity (Curzon and Green, 1969; Nemeth, 1976; Nomura, 1965) . However, Tdo2 242 expression in the frontal cortex of the rat brain was unchanged after acute stress despite an increase of Tdo2 in 243 liver using a qPCR assay that quantified all Tdo2 transcripts, i.e. Tdo2-Tot (Gibney et al., 2014) . The current 244 report is the first to quantify the regulation of the three known Tdo2 transcripts ( Fig. 1 ) in stressed mice to 245 identify distinct regulatory profiles. 246
Tdo2-FL expression is increased to 2.3-fold of controls in brain by restraint-stress ( Fig. 6A ). This effect 247 is paralleled by a 1.8-fold increase within astrocytes. Tdo2-FL expression in microglia is lower than brain and 48 astrocytes and unaffected by stress. Tdo2-FL expression within astrocytes from Ido1 KO mice was also doubled 49 by restraint-stress, but not within the brains from which they were derived. Astrocyte Tdo2-FL expression is 50 greater in Ido1 KO mice compared to the brain of wild-type mice, suggesting genetic deletion of Ido1 results in 51 specific compensatory Tdo2-FL upregulation within astrocytes. Although stress increased Tdo2-FL expression 52 in brain from wild-type mice, stress did not increase Tdo2-FL in brain of Ido1 KO mice. This finding suggests 253 another brain cell-type, possibly neurons (Lawson et al., 2016) , expressing Tdo2-FL is only stress-sensitive 54 when Ido1 is intact. Tdo2-FL is considerably higher in the liver relative to brain-regions and increased by stress 55 in both wild-type and Ido1 KO mice. 56
Tdo2-v1 is increased to 10.1-fold of controls by restraint-stress in brains from wild-type mice (Fig. 6B ).
257 Although Tdo2-v1 expression is greater in astrocytes and microglia relative to whole-brain, its expression in 58 these cells is unaffected by restraint. These data suggest the stress-induced increase in brain Tdo2-v1 is 59 mediated by neurons (or other glia) which also express Tdo2 (Lawson et al., 2016) . Unlike Tdo2-FL, Tdo2-v1 60 expression is similar across brain-regions. Thus, these data illustrate a unique expression pattern vs. Tdo2-FL 261 (despite the entire Tdo2-FL sequence encompassed within Tdo2-v1, Fig. 1 ). Like Tdo2-FL, there is no increase 262 in brain Tdo2-v1 expression in Ido1 KO mice, indicating a requirement of Ido1 for brain Tdo2-v1 induction. In 63 wild-type mice, hepatic Tdo2-v1 expression is greater than in brain-regions, but not significantly affected by 64 restraint-stress.
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Tdo2-v2 expression in brain of wild-type mice is increased 7.3-fold by restraint-stress ( Fig. 6C ). Tdo2-266 v2 expression in both astrocytes and microglia is greater than brain levels, yet unaffected by restraint. Like 67 Tdo2-v1, these data suggest the stress-induced increase in brain Tdo2-v2 is mediated by neurons or other glia. 68
Tdo2-v2 expression in astrocytes from Ido1 KO mice is decreased slightly but significantly by restraint. Tdo2-v2 69 expression is similar across brain-regions. In wild-type mice, Tdo2-v2 levels in liver were greater than brain-70 regions and increased by restraint. 71
Therefore, all three Tdo2 transcripts are increased by restraint-stress in brains of wild-type mice. The 72 increase in brain Tdo2-FL parallels the increase in astrocytes, whereas the increases in Tdo2-v1 and Tdo2-v2 73 are mediated by unidentified cell-types. Only Tdo2-FL and Tdo2-v2 are increased by restraint-stress in liver 74 relative to control mice. Thus, there is transcript-, tissue-and cellular-specificity of Tdo2 expression and 75 regulation by restraint-stress. 76
Other Kynurenine Pathway related gene expression & regulation by stress 77
The DOs are rate-limiting for Trp metabolism to Kyn, but Kyn itself is further metabolized into neuro-78 and immune-active kynurenines in a cell-specific manner. This specificity is achieved by differential expression Kynu (kynureninase) initiates Kyn metabolism to QuinA. Kynu expression is greater in microglia 286 relative to astrocytes and considerably higher in liver ( Fig. 7B ). These data confirming previous reports of 87 microglial enrichment of this enzyme within the brain (Guillemin et al., 2003 (Guillemin et al., , 2001 . Kynu expression is 88 highest in the hypothalamus with expression largely unaffected by stress, the exception being a decrease in the 89
hippocampus. 90
Kmo (kynurenine 3-monooxygenase) also initiates Kyn metabolism to QuinA. Kmo expression is 291 greater in microglia relative to astrocytes, but again considerably higher in liver. These data confirm previous 92 reports of microglial enrichment of this enzyme in the brain (Guillemin et al., 2003 (Guillemin et al., , 2001 . Kmo expression is 293 increased ~50% in astrocytes and ~20% in microglia by stress ( Fig. 7C ). 294
Haao (3-hydroxyanthranilate 3,4-dioxygenase) acts downstream of Kynu and Kmo to complete QuinA 295 synthesis. Haao expression is greater in microglia relative to astrocytes, but again considerably higher in liver. 96
Haao expression is slightly but significantly decreased by stress in both microglia and liver ( Fig. 7D ). Again, 97 these data confirm preferential expression of Haao by microglia in the brain (Guillemin et al., 2001; Heyes et 298 al., 1996) .
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The extremely high levels of Tdo2, Ido2 and especially the downstream enzymes within the liver 00 (relative to brain), attest to its ability to efficiently generate niacin and NAD (Bender and Olufunwa, 1988) . 01
Overall, since the DOs are considered rate-limiting in the Kynurenine Pathway, these changes in downstream 02 enzymes probably do not result in an overall shift in the relative ability to produce downstream kynurenines; 03 that is to say astrocytes will generate primarily KynA and microglia QuinA as limited by Kyn production by the 04
Discussion
306
Acute restraint-stress increased the expression of all three DOs within the mouse brain in a transcript-, 307 tissue-and cell-type specific manner. Brain and plasma levels of Kyn were found to be increased in stressed 308 mice relative to controls demonstrating a functional increase in DO activity following acute restraint-stress. 309
Remarkably, Ido1-v1, Ido2-v3 and Tdo-FL expression was increased by stress in astrocytes, but not microglia. 310
However, in comparison to wild-type mice, we found aberrant Ido2 and Tdo2 expression in Ido1 KO mice 311 demonstrating a necessity of Ido1 for normal Ido2 and Tdo2 regulation within the brain. The expression 12 patterns of downstream Kynurenine Pathway enzymes confirm the hypothesis that astrocytes are central 13 producers of KynA while microglia are equipped to produce primarily QuinA. Since only astrocyte DO 14 expression was increased by stress, these finding further implicate a key role for Kyn and KynA within the 315 neurobiology of stress-induced behaviors. 316
Acute stress increases gene expression of markers for stress and inflammation 317
The induction of Fkbp51 by restraint-stress in brain and liver ( Fig 1999) and IL-1β (Dunn, 1992) also increase glucocorticoid release. Extending our understanding by which 325 inflammatory mediators are regulated by the stress response (or vice versa) is out of the scope of this study; 326 however, we are interested in how these confirmed stress responses affect the Kynurenine Pathway. 327 capability (Lawson et al., 2016) . Thus, the inability of stress to induce Ido2-v3 and Tdo2 variants in Ido1 KO 34 mice may also be involved in the lack of Kyn induction in Ido1 KO mice. 35 Wang et al., 2010) and synergistically by inflammatory mediators plus corticosteroids, although in a transcript-338 specific manner (Brooks et al., 2016b) . Within the brain and liver of naïve mice, Ido1-FL and Ido1-v2 339 expression was extremely low, similar to our previous report (Brooks et al., 2016b) . Ido1-FL and Ido1-v2 340 expression were not increased by restraint-stress in the current study; however, a previous study observed a fold increase in whole-brain Ido1-FL following acute combined acoustic and restraint-stress of female BALB/c 42 mice (Kiank et al., 2010). Whether the difference between that of Kiank and our study is due to a stronger 43 stressor (acoustic+restraint vs. restraint), different mouse strain (BALB/c vs. C57BL/6J) or sex (female vs. Ido1-v1 is the major Ido1 transcript within the naïve mouse brain, and its expression is increased by LPS 52 in vivo (Brooks et al., 2016a) and IFNγ ex vivo (Brooks et al., 2016b) . IFNγ also induces Ido1-Tot expression in 353 astrocytes (Kwidzinski et al., 2005) and microglia (Yadav et al., 2007) . However, the current data suggest IFNγ-354 independent stimuli must be responsible for Ido1-v1 induction in astrocytes by stress. Although Ido-v1 was not 355 increased by stress in whole-brain, its expression was increased by stress in the frontal cortex and hypothalamus 56 ( Fig. 4) , likely within astrocytes. The significance of the cortex and hypothalamus sensitivity to restraint-induced 57 Ido1-v1 induction relative to behavior remains to be determined. 58
Acute stress increases plasma and brain kynurenine in wild-type, but not Ido1
Acute stress increases Ido1-v1 expression in astrocytes and select brain-regions 36
Astrocytes are a heterogeneous population of related cells (Guillemin and Brew, 2010) varying in 359 functionality across brain-regions (Sery et al., 2015) . Previous reports assessing Ido1-Tot indicated primary 360 cultures of murine astrocytes do not express Ido1 (Kwidzinski et al., 2005) . By contrast, we detected Ido1-v1 361 expression in freshly isolated astrocytes, albeit at lower levels compared to the brains from which they were 62 isolated. Thus, the distribution of Ido1 transcripts is cell-type specific. Astrocytes are not the major source of 363 central Ido1-v1, but a 4.8-fold induction by stress could be critical to changes in astrocyte Kyn and KynA 364 production. 365
We detected minimal expression of Ido1 transcripts in liver which were unaffected by restraint-stress; 366 however, Ohta found increased hepatic Ido1-Tot following 6 h of water-immersion restraint-stress. This was 367 associated with increased hepatic and serum IFNγ (Ohta et al., 2016). Thus, it is possible that our acute stress 368 was insufficient for inducing IFNγ necessary for hepatic Ido1 induction.
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Ido2 expression in the brain and liver is consistent with our previous report (Brooks et al., 2016b) . For 71 example, Ido2-FL is enriched in the striatum, yet its expression is highest in liver (Fig. 5A ). Sets of Ido2 72 transcripts share expression patterns: Ido2-FL and Ido2-v4 are enriched in striatum, while Ido2-v1, Ido2-v2,  73 Ido2-v3, Ido2-v5 and Ido2-v6 are enriched in hypothalamus, but Ido2-v8 was not detected in the brain ( Fig. 5  74 and S1). The cell-types responsible for these differences are unknown. Cells within distinct brain-regions must 75 either differently splice Ido2 pre-RNA to generate different transcripts or utilize different promoter regions to 76 initiate transcription thereby generating different transcripts. The same can be said for Ido1 and Tdo2 transcript 77 profiles, albeit Ido2 is the most complex. 78
Mazarei found enriched expression of both Ido1-Tot and Ido2-Tot in striatum and that Ido1 KO mice were 79 deficient in Ido2-Tot within the striatum (Mazarei et al., 2013), reflecting our expression pattern for Ido1-v1 or 80
Ido2-FL, Ido2-v4 and Ido2-v6, respectively (Fig. 4, Fig. 5 and Fig. S1 ). Moreover, unlike wild-type mice, Ido2-81 v3 expression was not increased by stress in Ido1 KO mice (Fig. 5B) , further highlighting the dysregulation of 82
Ido2 within the brain in the absence of Ido1. These findings raise the issue as to whether behavioral changes 83 seen with Ido1 KO mice may also be dependent on reduced basal Ido2 expression and the non-inducible nature of 84 Ido2 in Ido1 KO mice. This is important, as Ido1 is considered anti-inflammatory, whereas Ido2 acts as a pro-85 inflammatory facilitator most likely via an enzymatic-independent mechanism (Merlo and Mandik-Nayak, 386 2016). 387
Astrocytes and microglia also differentially express Ido2 transcripts. Ido2-v3 ( Fig. 5B ) was the only 388 Ido2 transcript upregulated by stress and this only occurred within astrocytes. When cloned and overexpressed, 89 the enzymatic activity of the protein encoded by Ido2-v3 was less than that from Ido2-FL (Metz et al., 2014). 90 Thus, the enzymatic or non-enzymatic role that stress-responsive Ido2-v3 plays in animal behavior, brain 391 function and Kyn production remains to be determined. 92
In the current study, both astrocytes and microglia were found to express all three DOs, albeit to varying 93 degrees. However, the DOs may not be universally co-expressed. As an example, within the liver Ido2 and 94 In contrast, Ido2-v1, Ido2-v2, Ido2-v5 and Ido2-v6 expression levels are higher in all brain-regions 06 compared to liver ( Fig. 5 and Fig. S1 ). These data clearly illustrate the utilization of alternative-gene processing 07 to produce distinct Ido2 transcript profiles. The ability to fine-tune the Ido2 transcriptome endows the brain and 08 liver with precise regulatory control for responding differentially to stressors. 09 Hepatic Ido2 expression did not appear to differ significantly between wild-type and Ido1 KO mice, 410 although Kolodziej (Kolodziej, 2013) found decreased Ido2 expression in inguinal lymph nodes of Ido1 KO mice. 11
Nevertheless, stress resulted in decreased hepatic Ido2-FL, Ido2-v3 and Ido2-v4 and striatal Ido2-v1. Again, the 12 functional consequences of these tissue-specific changes on behavior remain undetermined. 13
Determining the mechanism behind perturbed (diminished) expression of specific Ido2 transcripts in 14 
Acute stress increases Tdo2-FL expression in brain, astrocytes and liver 435
Our data ( However, stress did not induce Tdo2 transcripts in selected brain-regions (PFC, Stri, Hippo and Hypo). 41
Similarly, Gibney reported no acute stress-induced change in Tdo2-Tot mRNA within the PFC (Gibney et al., 42 2014 ), further implicating other brain-regions such as the cerebellum or brain stem (Kanai et al., 2009; Mazarei 43 et al., 2013; Pawlak et al., 2000) in the central Tdo2 transcriptional response to acute restraint-stress. 44 Shimazu first reported increased hepatic Tdo2 activity (in vitro conversion of Trp to Kyn by liver 45 homogenate) following peripheral administration of corticosterone, or by stimulation of the hypothalamic 46 sympathetic nucleus, both effects seemingly independent of adrenal secretions. However, hepatic Tdo2 447 enzymatic activity was greater when the hypothalamus of animals with intact adrenals were stimulated 48 (Shimazu, 1964) . Indeed, the addition of the synthetic glucocorticoid dexamethasone to primary hepatocytes 449 increases Tdo2 activity (Nakamura et al., 1980; Noda et al., 1983) and mRNA levels (Nakamura et al., 1987; 450 Niimi et al., 1983; Ott et al., 2015) . Acute stress also increases hepatic Tdo2 activity (Curzon and Green, 1969; 451 Gibney et al., 2014; Nomura, 1965; Ohta et al., 2016) , an effect either reportedly requiring (Curzon and Green, 452 1969) or only partly moderated by adrenal secretions (Nomura, 1965; Ohta et al., 2016) . Collectively, these data 453 suggest hepatic Tdo2 activity is increased in a glucocorticoid-dependent (stress, corticosterone-induced) and 454 glucocorticoid-independent (direct hypothalamic stimulation) manner. 455
Whether glucocorticoids directly mediate the upregulation of all three Tdo2 transcripts in the brain is 456 unlikely since dexamethasone only upregulated Tdo2-FL in brain-slice cultures (Brooks et al., 2016b) . Thus, 457
Tdo2-FL induction likely represents the adrenal-dependent transcript in the aforementioned studies, whereas 58
Tdo2-v1 and Tdo2-v2 represent the adrenal/glucocorticoid-independent transcripts. Again, it appears that tissues 459 utilize different DO transcripts to fine-tune responses to specific physiologic inputs. Defining the Tdo2 460 transcriptome within specific hepatic cell-types is needed to completely understand Tdo2 (and Ido) regulation in 461 response to stress. 462
Following acute stress, only the glucocorticoid-responsive Tdo2-FL transcript was induced within 463 astrocytes. Curiously, the stress-induced increase in Tdo2-FL was preserved in astrocytes of Ido1 KO mice but 464 not within whole-brain homogenate of Ido1 KO mice (Fig. 6A) . Thus, although genetic deletion of Ido1 blocks 465 stress-induced increases of astrocyte Ido2-v3 (Fig. 5B) , astrocyte Tdo2-FL expression is still increased by stress 466 in Ido1 KO mice (Fig. 6A ). Hence, in astrocytes, the induction of Ido2 is Ido1-dependent, but the induction of 67
Tdo2 is Ido1-independent. Tdo2 (unknown transcript) is present primarily in neurons and astrocytes (McCusker 468 et al., 2014) . The stress-induced increase in Tdo2-v1 and Tdo2-v2 in whole brain is not seen in astrocytes (or 69 microglia). Presumably, this induction is occurring within neurons and surprising requires Ido1 (Fig. 6 ). 
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Downstream Kynurenine Pathway genes and their regulation by stress 74
The enzymatic machinery downstream of the DOs define the cellular-specificity of Kyn metabolism into 475 neuroactive kynurenines (Dantzer et al., 2008; McCusker et al., 2014) . Astrocytes expressed significantly more 476
Kat2 and less Kynu, Kmo and Haao than microglia ( Fig. 7 A-D (Fig, 7) . These findings suggest that the increase in KynA is controlled by elevated astrocyte DO 490 expression without a necessary increase in Kat2. In contrast to the mild inductions by stress, acute LPS-induced 491 inflammatory responses cause 2 to 5 fold increases in KMO expression (dependent on brain region) without (Miller et al., 2006) are greater post mortem in Schizophrenic patients than controls. One 508 hallmark of Schizophrenia is the reduced ability of a 'prepulse' (or weak cue) to inhibit the natural the natural 509 startle response to a subsequent stronger stimulus (Kumari et al., 2000) . Prepulse inhibition is also disrupted by 10 increased brain 
Conclusion
522
Although several studies have implicated the Kynurenine Pathway in stress-induced depression-like 23 behavior, the cellular-origin and transcript-specificity of the DOs remained undefined. Herein, we report that all 24 three DOs were upregulated by stress in a cell-and transcript-specific manner. Specifically, Ido1-FL, Ido2-v3 25 and Tdo2-FL were all increased in astrocytes. In contrast, brain Tdo2-v1 and Tdo2-v2 were upregulated by 26 stress, a response that is independent of astrocyte or microglial expression. When only investigating whole-527 brain or brain-regions these subtle but critical changes are easily overlooked. Remarkably, stress did not 28 increase several DO transcripts in brain of Ido1 KO mice, suggesting an Ido1 requirement for their induction. 29
Thus, our data highlight a significant perturbation of Ido2 and Tdo2 regulation within the brain of Ido1 KO mice. 30
The specific role for astrocytes in acute stress is supported by reports of stress-induced increases in central 531 Ido1-v1 expression. Expression was quantified in whole-brain, glia, liver and several brain-regions: the 849 prefrontal cortex (PFC), striatum (Stri), hippocampus (Hippo) and hypothalamus (Hypo). Samples from 850 Ido1 KO mice did not express any Ido1 transcript. Ido1-FL and Ido1-v2 transcripts were not detected by 51 qPCR. *p<0.05 comparing Ctrl to Res within tissue or glia. φ p<0.05 compared to other brain-regions. 52 .05 compared to other brain-regions. δ p<0.05 liver compared to all brain-regions. 64 Figure S1 . Additional Ido2 transcripts and their expression following acute stress. Tissue and glia from 865 control (Ctrl) and restraint-stressed (Res) mice sacrificed 2 h after a 3 h restraint were analyzed for 866 additional Ido2 transcripts. (A) Ido2-v1 expression in brain is greater than astrocyte and microglia levels, 67 indicating these cell-types are not the major source of Ido2-v1. Hypothalamic Ido2-v1 expression was 68 greater than all other brain-regions. Stress slightly decreased Ido2-v1 relative to controls in the striatum. 869
Ido2-v1 expression was not detectable in the liver. (B) Ido2-v2 expression was greater in microglia than 70 brain with brain and astrocytes having similar expression levels, indicating that microglia and astrocytes 71 are a major source of central Ido2-v2. In Ido1 KO mice, Ido2-v2 was greater in astrocytes compared to 72 brain, and increased following restraint-stress relative to Ctrl. Within brain-regions, Ido2-v2 expression 873 differed with Hypo > PFC = Stri > Hippo > liver. Hypo Ido2-v2 was increased ~28% by stress relative to 874
Ctrl. (C) Ido2-v5/v2 expression did not differ in brain, astrocytes or microglia of Ctrl or stressed mice, 875 indicating a uniform expression pattern for this transcript. Ido2-v5/v2 expression in the hypothalamus 76 was greater than all other brain-regions. Hepatic Ido2-v5/v2 expression was not detected. Ido2-v5/v2 77 expression was not detected in brain or astrocytes of Ido1 KO mice. (D) Brain Ido2-v6/v2 expression was 878 greater than astrocyte and microglia, indicating these cell-types are not the major source of brain Ido2-879 v6/v2. In Ido1 KO mice, brain Ido2-v6/v2 expression was also greater than astrocyte levels. Ido2-v6/v2 880 expression was greater in Hypo than all other brain-regions. Hepatic Ido2-v6/v2 was not detectable. (E) 881
Ido2-v7 expression did not differ in brain, astrocytes or microglia of Ctrl or stressed mice or across brain-82 regions, indicating a uniform expression pattern for this transcript. Ido2-v7 was not detected in Ido1 KO 83 mice brain or astrocytes. Hepatic Ido2-v7 expression levels were greater than all other brain-regions. (F) 884 Ido2-v8 expression was only detected in liver. *p<0.05 comparing Ctrl to Res samples within tissue or 85 glia. φ p<0.05 compared to other brain-regions. δ p<0.05 liver compared to all brain-regions. 886
Overall these additional Ido2 transcripts are relatively impervious to stress. However, Ido2 transcripts 887 fall into two general categories: 1) hepatic expression > than brain (Ido2-FL, Ido2-v3, Ido2-v4 ( Fig. 5) , 88
Ido2-v6 and Ido2-v8 ( Fig. S1)) ; 2) brain expression > than liver (Ido2-v1, Ido2-v2, Ido2-v5 and Ido2-v7 89 M A N U S C R I P T A C C E P T E D ACCEPTED MANUSCRIPT (Fig. S1) ). This illustrates a distinct regulatory mechanism driving the expression of Ido2, albeit with as 890 yet unrecognized functional consequences. 891
